Hot Stocks

The stock market changes from minute to minute, and what’s hot today may not be hot tomorrow. Our expert analysts spot hot stocks that are heating up before the crowd swoops in to bid prices higher, and our journalists sift through the noise to shine a light on trending investments -- in spaces ranging from quantum computing to marijuana stocks -- to determine whether they’re actually worth your time.

Five Below Earnings: FIVE Stock Jumps 4% on Q2 Beats

Five Below (FIVE) earnings for the retail company's second quarter of 2020 have FIVE stock up after-hours Wednesday on beats.

Mastercard Is at a Peak and Is Too Expensive to Buy Now

Mastercard is at a peak and is too expensive to buy now. MA stock is expensive at 54 times 2020 earnings, even discounting its historical 19.6% annual EPS growth rate.

Vera Bradley Earnings: VRA Stock Shoots 34% Higher on Q2 Beats

Vera Bradley (VRA) earnings for the luggage and handbag company's second quarter of fiscal 2021 have VRA stock taking off on Wednesday.

Should You Invest in Exxon Mobil Stock After It’s Been Cancelled?

Exxon Mobil stock continues to slide after being removed from the Dow. Climate change activists claim credit, but this is really just about performance.

Guess? Earnings: GES Stock Surges 12% on Q2 Topper

Guess? (GES) earnings for the clothing retailer's second quarter of fiscal 2021 have GES stock heading higher on Wednesday.

DraftKings News: DKNG Stock Jumps 8% on Michael Jordan Relationship

DraftKings (DKNG) news for Wednesday includes NBA Hall of Famer Michael Jordan joining the company and DKNG stock soaring higher.

Is CRISPR Therapeutics Worth It Without Drugs?

We're still very early in the development of gene editing, and CRISPR Therapeutics is one of the first out of the block. But it's not hte final word.

Coronavirus Hazard Pay 2020: 10 Companies Paying Employees More for Working During Pandemic

Coronavirus hazard pay has some companies paying employees more during the crisis, as well as handing out extra benefits.

Macy’s Earnings: M Stock Climbs 4% Higher On Q2 Beats

Macy's earnings on Wednesday morning have M stock climbing higher after the company beat both EPS and revenue estimates from Wall Street.

Don’t Discount the Bears On Sorrento Stock

SRNE stock has been the target of a so-called "bear raid." But shorts make good points, and red flags remain for Sorrento.

Don’t Be Too Quick to Dismiss Landcadia Holdings

Among the recent SPACs generating headlines, Landcadia Holdings has raised more than a few eyebrows. But surprisingly, LCA stock has the potential to be a viable online gambling story.

At This Point, iBioPharma Is a Flash in the Pandemic

Sure, iBio hopes to win the Covid-19 vaccine race, but right now, IBIO stock investors aren't benefiting from the pursuit.

Is Advanced Micro Devices Stock Running Out of Steam?

Will Advanced Micro Devices' Q3 earnings be enough to spark another rally by AMD stock in November, or will the current plateau be extended?

There’s an Excellent Reason Buffett Keeps Buying Bank of America Stock

The legendary Warren Buffett's track record isn't perfect, but he's done extremely well. Thus, his BAC stock purchases are worth watching.

Do Not Consider Workhorse Group if Profits Are Your Thing

Workhorse Group delivered its first C-series electric step vans to customers. Despite a lack of profits, WKHS stock now has growth catalyst.

After AMD Stock Takes Out the $100 Level, Start Taking Profits

AMD stock is slightly overvalued above $90. But not by enough to offset what are strong fundamental and optical growth catalysts.

When It Comes to Virgin Galactic Stock, There Is Absolutely No Rush to Jump In

SPCE stock comes with a compelling story and a ton of risk. Bullish investors say to get on board now, but caution may be the better play.

Ford’s Latest CEO Change Is Sounding Familiar

Ford recently announced that CEO, Jim Hackett, is retiring. COO Jim Farley is taking the helm Oct. 1. F stock has moved sideways ever since.

Novavax’s Cinderella Tale is Heading Toward an Alternative Ending

As one of the viable Covid-19 vaccine producers, Novavax was a Cinderella story of 2020. But a harsh reality check is making NVAX stock look less credible.